Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
02/2011
02/01/2011CA2555633C Non-nucleoside reverse transcriptase inhibitors
02/01/2011CA2466140C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
02/01/2011CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
02/01/2011CA2315717C Inhibition of raf kinase using substituted heterocyclic ureas
01/2011
01/25/2011US7875647 Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
01/25/2011CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives
01/20/2011WO2009156074A8 Thiadiazolyloxyphenylamidines and use thereof as fungicides
01/20/2011US20110015408 Sulfonylpyrrolidine modulators of androgen receptor function and method
01/20/2011US20110015158 Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
01/19/2011CN101948466A Asymmetric heterocyclic ring substituent urea compound and preparation method and application thereof
01/18/2011US7872139 Heteroaryl-ureas and their use as glucokinase activators
01/18/2011US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent
01/18/2011CA2500964C Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
01/18/2011CA2310534C Methods and compositions for treating primary and secondary tumors of the central nervous system (cns)
01/13/2011WO2011004162A2 Compounds useful as medicaments
01/13/2011US20110010787 Soybean variety a1016497
01/13/2011US20110009457 Aminobenzamide Derivatives as Useful Agents for Controlling Animal Parasistes
01/13/2011US20110009418 Therapeutic agents useful for treating pain
01/13/2011CA2767291A1 Compounds useful as medicaments
01/12/2011EP2272836A1 Process for the preparation of bis-DMTB
01/12/2011EP2094677B1 Thiadiazole derivatives for the treatment of neuro-degenerative diseases
01/12/2011CN101945848A Tetrasubstituted benzenes
01/12/2011CN101941951A Process for the preparation of bis-DMTD
01/06/2011US20110004000 Mitotic Kinesin Inhibitor
01/06/2011CA2707652A1 Process for the preparation of bis-dmtd
01/05/2011EP2268626A1 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of hsp90 chaperone and the intermediates for production thereof
12/2010
12/30/2010US20100331550 Thienothiophene derivatives
12/29/2010WO2010148963A1 Compounds having activity against hepatitis virus and use thereof
12/29/2010WO2010148650A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010WO2010148649A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010WO2010148488A1 Cathepsin cysteine protease inhibitors for the treatment of various diseases
12/29/2010CA2764956A1 Novel biphenyl and phenyl-pyridine amides
12/29/2010CA2762675A1 Heterocyclic antiviral compound
12/28/2010US7858647 Peroxisome proliferator-activated receptor agonists; insulin resistance; neurodegenerative disorders ; N-{2-[4-(5-Isopropyl-[1,3,4]thiadiazol-2-ylsulfamoyl)-phenyl]-ethyl}-2-methoxy-4-trifluoromethyl-benzamide
12/28/2010US7858642 Substituted hydroxyethylamine aspartyl protease inhibitors
12/23/2010WO2010146083A1 Anthelmintic agents and their use
12/23/2010WO2010091876A3 Small molecule bradykinin b1 receptor antagonists
12/23/2010US20100324025 Antibacterial Agents
12/23/2010CA2765130A1 Anthelmintic agents and their use
12/22/2010CN101921245A Sulfonamides compound for inhibiting carbonic anhydrase II and synthesis method and application thereof
12/22/2010CN101921244A Derivative of 4-methyl-1,2,3-thiadiazole containing 4-(1,1,2,2-tetrafluoroethoxy)-3,5-dichlorobenzene amino and synthesis method and application thereof
12/16/2010US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties
12/16/2010US20100317701 Heterocyclic inhibitors of necroptosis
12/15/2010EP2260028A2 Selective androgen receptor modulators
12/15/2010CN1909909B 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept
12/15/2010CN101492429B Purification method for benzo-[1,2,3]-thiadiazole-7-methanoic acid trifluoro ethyl ester
12/15/2010CN101153028B Compounds with antimicrobial antiviral activity
12/14/2010US7851636 {2-[3-Cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial; antidiabetic agents
12/14/2010US7851635 which comprises thiadiazoline derivatives, effective in treatment of a disease associated with cell proliferation, such as restenosis, cardiac hypertrophy and immunologic diseases
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/09/2010US20100310493 Acetamide derivatives as glucokinase activators, their process and medicinal application
12/08/2010EP2258373A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer
12/08/2010EP2257536A2 Cyclic diaryl ether as antagonists of prostaglandin d2 receptors
12/08/2010EP2257528A2 1 ibeta-hydroxysteroid dehydrogenase inhibitors
12/07/2010US7847100 enzyme ihibitors such as 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide, used for treating neurodegenerative diseases
12/07/2010US7846956 Malononitrile compound as pesticides
12/07/2010CA2374995C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010US20100305109 Potassium channel modulators
12/01/2010CN101903365A Spiro-condensed 1, 3, 4-thiadiazole derivatives for inhibiting KSP kinesin activity
12/01/2010CN101899042A 4-substituted-1,2,3-thiadiazole formoxyl ureide compound, preparation method and application thereof
12/01/2010CN101899021A Fluorescent compound and application thereof in detecting trace methylamphetamine
12/01/2010CN101898982A Npy y5 antagonists
11/2010
11/25/2010US20100298388 Substituted benamidines as antibacterial agents
11/25/2010US20100298387 IL-8 Receptor Antagonists
11/25/2010US20100298328 1-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-Arylalkanes
11/25/2010US20100298278 Inhibitors of beta-secretase for the treatment of alzheimer's disease
11/24/2010EP2252590A1 Substituted sulfonic acid amide compounds
11/24/2010EP1280764B1 Inhibitors of histone deacetylase
11/24/2010CN101891710A 4-halogenated methyl-1,2,3-thiadiazole compounds and preparation method and application thereof
11/24/2010CN101891709A 5-halogenated methyl-1,2,3-thiadiazole compound and preparation method and use thereof
11/24/2010CN101891708A Diacylhydrazine compounds containing 4-methyl-1,2,3-thiadiazole groups, preparation method and application thereof
11/24/2010CN101890166A Combination of organic compounds
11/24/2010CN101045715B Heterocycle inhibitor for glycogen synthase kinase gsk-3
11/18/2010WO2010130944A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130934A2 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010033543A3 Substituted benzamides as cannabinoid receptor ligands
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292472 Prophylactic and therapeutic medicine for malaria
11/18/2010US20100292274 Haloalkyl heteroaryl benzamide compounds
11/18/2010US20100292240 Sulfonamide compounds
11/18/2010CA2761876A1 Haloalkyl heteroaryl benzamide compounds
11/18/2010CA2761660A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/11/2010WO2010127928A1 Insecticidal compounds
11/11/2010WO2010074587A3 5-o-substituted 3-n-aryl-1,3,4-oxadiazolones for medical use
11/11/2010US20100286171 Phenylacetamide derivative
11/11/2010US20100286169 Antibacterial Sulfone and Sulfoxide Substituted Heterocyclic Urea Compounds
11/11/2010US20100286129 Novel benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
11/11/2010US20100285957 Thiazolyloxyphenylamidines or thiadiazolyloxyphenylamidines and their use as fungicides
11/11/2010CA2759592A1 Insecticidal compounds
11/10/2010EP1937659B1 Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
11/10/2010CN1918134B Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors
11/10/2010CN101883760A Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
11/10/2010CN101323603B Preparation of 2-amido-1,3,4-thiadiazoles
11/09/2010US7829563 sleep disorders; (R)-2-[(S)1-(5-chloro-2-methoxy-phenyl)-3-(6-trifluoromethyl-pyridin-3-yl)-propylamino]-2-(4-fluoro-phenyl)-N-methyl-acetamide
11/04/2010WO2010125991A1 Method for control of fish parasites
11/04/2010US20100280079 0novel, 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
11/04/2010CA2759155A1 Antiparasitic agent for fish and method of controlling proliferation of fish parasites
11/03/2010EP2246339A1 Derivatives of benzothiazepine and their use as modulators of AMPA and NMDA receptors
11/03/2010EP2245022A2 Antagonists of prostaglandin d2 receptors
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 100